Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP

Answer the questions:

1. What are the 10 biggest for-profit companies in this field?
   • How is the market distributed?
   • Where are they located? Are there any incentives for specific locations?
   • Correlate them with their main outputs (Data. Narratives. Tools)
   • Understand and identify cases where these companies are “experimenting” or “adopting” commons-based approaches
   • Identify these cases and treat them as entities that will also be placed in our mapping*device (the quadrants)
   • Identify what companies are the “Microsofts” of the field and what companies are the “IBMs” of the field

	2006 Revenue ($m)	Headquarters	Primary Outputs	Instances of Commons-based approaches
Amgen	14268	Thousand Oaks, California	ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline	?
Genentech	9284	South San Francisco	synthetic human insulin – their first famous product, many others produced using the Boyer-Cohen rDNA process	?
Genzyme	3187	Cambridge, Massachusetts	Cerezyme (treats Gaucher's disease) accounts for 30% of company's revenue	?
Gilead Sciences	3026	Foster City, California	11 commercial products	?
Biogen Idec	2683	Cambridge, Massachusetts	Treatments for Crohn's disease, non-Hodgkin's lymphoma, and multiple sclerosis	?
Cephalon	1764	Frazer, Pennsylvania	Specializes in treating neurodegenerative diseases	?
MedImmune	1277	Gaithersburg, Maryland	Only major drug prevents respiratory diseases in infants	?
Celgene	899	Summit, New Jersey	treatments for erythema nodosum leprosum ("ENL") and multiple myeloma	?
Abraxis BioScience	766	Los Angeles, California	uses patented nanoparticle technology to produce products for metastatic breast cancer	?
ImClone Systems	678	New York, New York	acquired by Eli Lilly, tried to produce Erbitux for Colorectal Cancer, but failed to win FDA approval	?